Educational Partnership: Carl Zei Showcasing Use of Microscopy in Dentistry with Educational Partnership

JENA/Germany, PHILADELPHIA/Pennsylvania/USA, 08.03.2013.

A special dedication of the new clinic, which opened for patient care in January, was held on March 1. "This collaboration will enable us to clearly demonstrate the many practical benefits of microscopy to future dentists during their training. This will allow us to build awareness and advance microscopy within this relatively young market over the long term," says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG.

Carl Zeiss has outfitted Penns new endodontic clinic with ZEISS OPMI pico or OPMI PROergo surgical microscopes. This facility is the teaching clinic for the postdoctoral students in Penn Dental Medicine's graduate dental education program in endodontics as well as the training center for the Department of Endodontics continuing education programs in microsurgery.

"You can only treat what you can see," says Dr. Syngcuk Kim, the Louis I. Grossman Professor of Endodontics at Penn Dental Medicine, who over the past 20 years has established Penns Department of Endodontics as a leader in the integration of the operating microscope into conventional and surgical endodontic education and practice. The illumination and magnification of the surgical microscope have made it a vital tool in modern endodontic education and practice. "Microscopy is the key to more quality and reliability in dentistry," adds Dr. Ludwin Monz.

Carl Zeiss also supports Penn Dental Medicine's international continuing education programs through a hands-on program as part of the Penn Endodontic Global Symposium, held in Korea in 2010, Germany in 2011, Japan in 2012, and most recently in India in February 2013.



Dr. Meetu Kohli explaining to Dr. Kosuke Tanaka, a resident dentist from Japan, the benefits of a surgical microscope for dentistry.

Jann Gerrit Ohlendorf

Director Corporate Communications

Carl Zeiss Meditec AG

Phone: +49 3641 220-331

Fax: +49 3641 220-332

E-Mail:

press.meditec@zeiss.com

Henriette Meyer

Director Investor Relations

Carl Zeiss Meditec AG

Tel.: +49 3641 220-106

Fax:

E-Mail:

investors.meditec@zeiss.com

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG (ISIN: DE0005313704) is one of the world's leading medical technology companies. The company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumables. The company creates innovative visualization solutions in the field of microsurgery. Carl Zeiss Meditecs medical technology portfolio is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy. In fiscal year 2011/12 (ended 30 September) the companys around 2,400 employees generated revenue of just under EUR 862 million. Carl Zeiss Meditec headquarters are located in Jena, Germany.

The company has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research in India (CARIn) in Bangalore, India, and the Carl Zeiss Innovation Center for Research and Development in Shanghai, China, strengthen the companys presence in these fast-growing countries. Around 35 percent of Carl Zeiss Meditec shares are in free float. The remaining approx. 65% are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, Carl Zeiss has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. Carl Zeiss AG, Oberkochen, is fully owned by the Carl Zeiss Foundation.

For more information please go to: www.meditec.zeiss.com

Number: 0032-2013-ENG OP

Number of Words: 409

Number of Characters: 3064

LINK:	http://applications.zeiss.com/C1256A770030BCE0/WebViewTopNewsAllE/BE74...
	See more stories from zeiss

Most recent headlines